Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
04/02/2026
Novo Nordisk ADR resumes trading, with the decline expanding to 6%. The company had previously stated that sales would decline this year.
Latest
2 m ago
Shares of Novo Nordisk (NVO.N) listed in the United States fell more than 13% on Tuesday. Prior to this, the company unexpectedly issued a warning that its sales in 2026 would decline more severely than expected due to price pressure affecting the sales of its popular diabetes and weight loss drugs in the United States. The Danish company expects global sales for the full year of 2026 to decline by 5% to 13% compared to 2025 (excluding exchange rate fluctuations). In contrast, sales for the full year of 2025 increased by 10%. The company stated that sales in the United States will decrease due to the price reduction of drugs including Ozempic and Wegovy. They pointed out that the company recently reached an agreement with the Trump administration to lower drug prices. The main components of these two drugs will also lose patent exclusivity in certain countries outside of the United States, which may open up competition from low-cost generic drugs. The deteriorating outlook is another piece of bad news for this once rapidly growing company, which was a pioneer in the weight loss drug market.
3 m ago
The night market for the Shanghai Futures Exchange crude oil futures 2510 contract closed up 1.78%, at 457.80 yuan per barrel. The night market for Shanghai gold rose 4.20%, and Shanghai silver rose 5.93%.
12 m ago
The NASDAQ China Golden Dragon Index fell more than 2%, Daquan New Energy fell 7.93%, Bilibili fell 5.05%, Xunlei fell 4.85%, Kingsoft Cloud fell 4.77%, and Ehang fell 4.67%.
13 m ago
"HP signs multi-year licensing agreement with Karamba company to provide security protection for HP printers."
16 m ago
On Tuesday, the overnight reverse repurchase agreement (reverse repo) usage by the Federal Reserve was $17.85 billion, down from $104.15 billion reported on the previous trading day.
See all latest